1. Home
  2. ABCL vs AGYS Comparison

ABCL vs AGYS Comparison

Compare ABCL & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$12.61

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$100.40

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
AGYS
Founded
2012
1963
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.1B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ABCL
AGYS
Price
$12.61
$100.40
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$8.40
$111.67
AVG Volume (30 Days)
4.4M
173.4K
Earning Date
05-11-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
67.07
EPS
N/A
0.32
Revenue
$75,128,000.00
$319,312,000.00
Revenue This Year
N/A
$17.65
Revenue Next Year
$21.85
$14.36
P/E Ratio
N/A
$313.28
Revenue Growth
160.56
15.85
52 Week Low
$2.75
$61.50
52 Week High
$13.18
$144.82

Technical Indicators

Market Signals
Indicator
ABCL
AGYS
Relative Strength Index (RSI) 65.97 37.61
Support Level $10.38 $94.74
Resistance Level N/A $114.23
Average True Range (ATR) 0.61 3.73
MACD -0.01 -1.43
Stochastic Oscillator 79.02 11.17

Price Performance

Historical Comparison
ABCL
AGYS

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About AGYS Agilysys Inc.

Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.

Share on Social Networks: